Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Score | Market Cap | Price | 1d % | EBITDA | P/E | D/E |
|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $4.56B | $161.10 | 0.54% | $17.90M | 402.75x | 0.05 | |
| TGTX | TG THERAPEUTICS INC | NASDAQ | Biotechnology | $2.50B | $16.19 | -1.40% | $25.89M | 179.89x | 1.05 | |
| SRPT | SAREPTA THERAPEUTICS INC | NASDAQ | Biotechnology | $12.63B | $133.66 | 2.32% | $91.13M | 326.00x | 2.36 | |
| VNDA | VANDA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $280.78M | $4.88 | 4.27% | $9.35M | 122.00x | 0.19 | |
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $2.55B | $24.52 | -2.15% | $122.89M | 21.32x | 0.20 | |
| GMAB | GENMAB A | NASDAQ | Biotechnology | $19.65B | $29.72 | 7.22% | N/A | 24.75x | 0.13 | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $1.79B | $31.57 | -0.38% | $237.47M | 13.43x | 0.64 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $15.65B | $82.44 | -1.62% | $359.85M | 75.63x | 0.36 | |
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $5.06B | $39.91 | 0.23% | $451.95M | 18.74x | 19.68 | |
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $12.07B | $53.76 | 1.26% | $1.11B | 16.14x | 0.32 | |
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $16.97B | $28.41 | -1.22% | $1.32B | 11.19x | 0.62 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $137.60M | $2.03 | 1.50% | $55.39M | 2.78x | 0.19 | |
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $6.38B | $21.90 | -0.99% | $312.76M | 34.22x | 0.32 | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | $6.93B | $110.01 | 0.66% | $1.16B | 21.03x | 2.06 | |
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $12.15B | $77.29 | 2.24% | $372.91M | 54.82x | 0.39 | |
| PBYI | PUMA BIOTECHNOLOGY INC | NASDAQ | Biotechnology | $234.44M | $4.86 | -2.02% | $41.45M | 14.73x | 3.20 | |
| BNTX | BIONTECH SE | NASDAQ | Biotechnology | $22.04B | $92.72 | 0.52% | $1.51B | 22.04x | 0.14 | |
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $1.09B | $7.37 | -1.73% | $50.76M | 14.17x | 0.42 | |
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.73B | $14.72 | -2.00% | $127.65M | 21.97x | 0.21 | |
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $554.96B | $123.05 | -0.78% | $17.67B | 42.83x | 2.02 | |
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $105.45B | $957.00 | 2.07% | $4.55B | 26.50x | 0.27 | |
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $11.64B | $262.40 | 1.65% | $1.49B | 11.74x | 0.22 | |
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $103.60B | $401.08 | 0.23% | $4.61B | 28.55x | 0.29 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.